Maurizio Sanguinetti Selected Research

Maurizio Sanguinetti Research Topics

Disease

75	Infections 08/2022 - 01/2002
26	COVID-19 08/2022 - 05/2020
22	Sepsis (Septicemia) 08/2021 - 09/2003
12	Candidiasis (Moniliasis) 12/2022 - 03/2008
10	Neoplasms (Cancer) 01/2022 - 07/2006
10	Mycoses (Diseases, Fungus) 06/2021 - 12/2011
9	Tuberculosis (Tuberculoses) 05/2021 - 05/2006
8	Clostridium Infections 07/2021 - 05/2014
8	Aspergillosis 11/2019 - 12/2011
7	Candidemia 10/2020 - 06/2007
6	Inflammation (Inflammations) 01/2020 - 02/2009
5	Pneumonia (Pneumonitis) 12/2021 - 06/2016
5	Invasive Candidiasis 06/2021 - 01/2010
5	Critical Illness (Critically Ill) 01/2021 - 09/2017
5	Communicable Diseases (Infectious Diseases) 07/2020 - 01/2015
5	Invasive Fungal Infections 12/2019 - 12/2012
4	Bacteremia 01/2021 - 04/2004
4	Urinary Tract Infections (Urinary Tract Infection) 10/2017 - 09/2010
3	Fibrosis (Cirrhosis) 01/2022 - 12/2018
3	Bacterial Infections (Bacterial Infection) 01/2021 - 12/2014
3	Septic Shock (Toxic Shock Syndrome) 09/2020 - 09/2015
3	Coinfection 09/2020 - 05/2016
3	Cryptococcosis 12/2018 - 01/2003
3	Fusariosis 12/2012 - 12/2011
2	Dyspnea (Shortness of Breath) 04/2022 - 11/2021
2	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 01/2019
2	Dysbiosis 01/2022 - 05/2020
2	Glioblastoma (Glioblastoma Multiforme) 11/2021 - 06/2019
2	Keratitis 01/2021 - 07/2015
2	Virus Diseases (Viral Diseases) 01/2021 - 05/2016
2	Viremia 10/2020 - 01/2020
2	Necrosis 01/2020 - 12/2018
2	Vaginitis 11/2019 - 01/2019
2	Vulvovaginal Candidiasis 11/2019 - 01/2014
2	Colitis 03/2019 - 04/2014
2	Central Nervous System Infections (Central Nervous System Infection) 06/2016 - 08/2008

Drug/Important Bio-Agent (IBA)

18	Anti-Bacterial Agents (Antibiotics)IBA 08/2022 - 02/2004
16	Pharmaceutical PreparationsIBA 12/2022 - 03/2008
12	AzolesIBA 01/2020 - 02/2005
8	AntigensIBA 05/2022 - 08/2003
8	Fluconazole (Zonal)FDA LinkGeneric 09/2020 - 01/2003
7	AntibodiesIBA 05/2022 - 01/2010
6	Interleukin-6 (Interleukin 6)IBA 05/2022 - 09/2007
6	EchinocandinsIBA 06/2021 - 11/2010
5	RNA (Ribonucleic Acid)IBA 07/2021 - 01/2015
5	galactomannanIBA 11/2019 - 08/2003
5	Vancomycin FDA LinkGeneric 01/2018 - 01/2012
4	Messenger RNA (mRNA)IBA 08/2022 - 06/2006
4	CytokinesIBA 05/2022 - 12/2018
4	C-Reactive ProteinIBA 04/2022 - 02/2009
4	Peptides (Polypeptides)IBA 02/2022 - 12/2011
4	Immunoglobulin G (IgG)IBA 01/2022 - 01/2014
4	graphene oxideIBA 07/2021 - 12/2016
4	Voriconazole (Vfend)FDA LinkGeneric 01/2021 - 07/2007
4	16S Ribosomal RNAIBA 05/2020 - 07/2006
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2006
4	EnzymesIBA 10/2017 - 08/2003
4	DNA (Deoxyribonucleic Acid)IBA 06/2016 - 02/2009
4	Antifungal AgentsIBA 07/2015 - 08/2006
4	Amphotericin B (Amphotericin)FDA LinkGeneric 11/2013 - 08/2006
4	Caspofungin (Cancidas)FDA Link 04/2013 - 08/2006
4	beta-Lactamases (beta-Lactamase)IBA 09/2008 - 02/2004
4	CoagulaseIBA 08/2008 - 09/2003
3	SodiumIBA 10/2021 - 04/2014
3	Carbapenems (Carbapenem Antibiotics)IBA 08/2021 - 01/2020
3	polyglucosanIBA 06/2021 - 09/2017
3	Antiviral Agents (Antivirals)IBA 10/2020 - 12/2018
3	Biological ProductsIBA 05/2020 - 03/2006
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 09/2017
3	Valacyclovir (Valtrex)FDA LinkGeneric 01/2020 - 11/2019
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 06/2019 - 09/2010
3	liposomal amphotericin B FDA Link 03/2019 - 05/2012
3	MannansIBA 01/2019 - 01/2010
2	Volatile Oils (Essential Oils)IBA 12/2022 - 05/2020
2	fibrin fragment D (D-dimer)IBA 04/2022 - 11/2021
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022 - 01/2019
2	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2021 - 07/2006
2	Therapeutic UsesIBA 11/2021 - 05/2020
2	Isoniazid (Ftivazide)FDA LinkGeneric 05/2021 - 07/2020
2	TriazolesIBA 02/2021 - 05/2011
2	Proton Pump InhibitorsIBA 01/2021 - 11/2016
2	SARS-CoV-2 envelope proteinIBA 11/2020 - 05/2020
2	LipopolysaccharidesIBA 01/2020 - 12/2018
2	GlucansIBA 01/2020 - 01/2019
2	EndotoxinsIBA 01/2020 - 12/2018
2	GoldIBA 01/2020 - 01/2015
2	DisaccharidesIBA 12/2019 - 01/2019
2	fenticonazoleIBA 11/2019 - 01/2019
2	Dextrans (Dextran)FDA Link 03/2019 - 04/2014
2	carbapenemaseIBA 04/2017 - 07/2014
2	Complement System Proteins (Complement)IBA 01/2017 - 09/2006

Therapy/Procedure

51	Therapeutics 08/2022 - 01/2002
8	Central Venous Catheters 03/2019 - 06/2007
7	Lasers (Laser) 02/2022 - 05/2014
6	Fecal Microbiota Transplantation 05/2022 - 01/2019
6	Transplantation 07/2021 - 05/2014
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2020
2	Length of Stay 10/2020 - 11/2019
2	Critical Care (Surgical Intensive Care) 01/2019 - 09/2017
2	Catheters 01/2019 - 01/2015